| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |